WorldQuant Millennium Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.4M Sell
95,027
-26,166
-22% -$9.33M 0.13% 169
2025
Q4
$39.7M Buy
+121,193
New +$38.4M 0.15% 154
2025
Q3
Sell
-203,205
Closed -$56.7M 504
2025
Q2
$56.7M Buy
203,205
+169,209
+498% +$47.9M 0.28% 104
2025
Q1
$10.6M Sell
33,996
-3,662
-10% -$1.08M 0.07% 237
2024
Q4
$9.82M Buy
+37,658
New +$11.2M 0.06% 250
2023
Q3
Sell
-8,124
Closed -$1.8M 355
2023
Q2
$1.8M Buy
8,124
+1,147
+16% +$266K 0.03% 300
2023
Q1
$1.69M Sell
6,977
-12,722
-65% -$3.12M 0.03% 272
2022
Q4
$5.17M Sell
19,699
-8,308
-30% -$2.23M 0.12% 207
2022
Q3
$6.31M Sell
28,007
-33,897
-55% -$8.22M 0.15% 171
2022
Q2
$15.1M Sell
61,904
-29,701
-32% -$7.28M 0.43% 83
2022
Q1
$22.2M Buy
91,605
+79,561
+661% +$18.3M 0.54% 49
2021
Q4
$2.71M Buy
+12,044
New +$2.54M 0.05% 254

Other funds holding AMGN

WorldQuant Millennium Advisors's AMGN Position: Q1 2026 in Review

WorldQuant Millennium Advisors reduced its Amgen (AMGN) stake by 22% in Q1 2026, selling an estimated $9.33M and leaving 95,027 shares worth $33.4M. The position accounts for 0.13% of the portfolio, ranked #169.

WorldQuant Millennium Advisors first reported a position in AMGN in Q4 2021 and has held it in 12 quarters since. The position peaked at $56.7M in Q2 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • WorldQuant Millennium Advisors held 95,027 shares of Amgen worth $33.4M as of Q1 2026.
  • WorldQuant Millennium Advisors sold 26,166 Amgen shares in Q1 2026, an estimated $9.33M.
  • Amgen made up 0.13% of WorldQuant Millennium Advisors's portfolio in Q1 2026, its #169 holding.
  • WorldQuant Millennium Advisors first reported a position in Amgen in Q4 2021 and has held it in 12 quarters since.
  • WorldQuant Millennium Advisors's Amgen position peaked at $56.7M in Q2 2025.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q1 2026, filed 15 May 2026.